Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combivent Respimat Adapter Performance in Ventilated Patients
NCT01969539Phase 4Terminated
- Sponsor
- Boehringer Ingelheim
- Start
- Oct 2013
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ipratropium bromide, salbutamol in chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Started Oct 2013; status: terminated.
02
Drugs
ipratropium bromidesalbutamol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01969539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01969539.